Literature DB >> 9639321

Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli.

A Fazel1, A Vincenot, A Malassiné, F Soncin, P Gaussem, E Alsat, D Evain-Brion.   

Abstract

A comparative study of thrombomodulin (TM), a potent natural anticoagulant, was performed in first trimester and term human placentae. Immunoreactive TM was observed on fetal vascular endothelium and syncytiotrophoblast at both gestational ages. Staining was stronger in term than in early placentae, particularly along the microvillous apical membrane of the syncytiotrophoblast. Similarly, a higher level of TM mRNA was detected by RT-PCR (P<0.02) and Northern blot analysis in extracts of whole term placentae. The localization of TM on syncytial microvilli was confirmed by electron microscopy after immunogold labelling. When isolated microvilli were compared at both gestational ages; a significant 2.3-fold increase in TM protein was observed in term microvilli as compared to first trimester microvilli by Western blot analysis (P<0.005) and ELISA (P<0.05). This higher level of TM in term microvilli was associated with an increase in its ability to activate protein C, from 3.7 +/- 1.2 to 8.7 +/- 4.2 mOD/min/microg protein +/- s.d. (P<0.01) in first trimester and term microvilli, respectively. The modulation of biologically active TM at the syncytial membrane exposed to maternal blood according to the length of gestation suggests that TM may be involved both in maternal haemostasis within the intervillous spaces, and also in the trophoblast differentiation process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639321     DOI: 10.1016/s0143-4004(98)90057-1

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  5 in total

1.  Saving placental thrombomodulin.

Authors:  Cha Han; Jing-Fei Dong
Journal:  Blood       Date:  2021-02-18       Impact factor: 22.113

2.  Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.

Authors:  Rashmi Sood; Shawn Kalloway; Alan E Mast; Cecilia J Hillard; Hartmut Weiler
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

Review 3.  Use of transgenic mice model for understanding the placentation: towards clinical applications in human obstetrical pathologies?

Authors:  V Sapin; L Blanchon; A F Serre; D Lémery; B Dastugue; S J Ward
Journal:  Transgenic Res       Date:  2001-10       Impact factor: 2.788

Review 4.  Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors:  Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal:  TH Open       Date:  2022-07-11

5.  Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro.

Authors:  Peter J O'Brien; Hideki Koi; Samuel Parry; Lawrence F Brass; Jerome F Strauss; Li-Peng Wang; John E Tomaszewski; Lane K Christenson
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.